Excimer light therapy with systemic corticosteroids improved severe chronic nodular prurigo and altered peripheral nerve fibers in the epidermis
- 04-05-2022
- Atopic Dermatitis
- Brief Report
- Authors
- Tsuyoshi Mitsuishi
- Mitsutoshi Tominaga
- Kazunori Miyata
- Sumika Toyama
- Utako Kimura
- Yasushi Suga
- Kenji Takamori
- Published in
- Lasers in Medical Science | Issue 9/2022
Excerpt
Chronic nodular prurigo (CNPG) is a pruritic, chronic skin disease clinically defined by hyperkeratotic or erosive nodules [1‐3]. In this study, we focus on patients with severe CNPG on the extremities and trunk who present with itchy skin lesions. CNPG is resistant to a variety of treatments. Most patients with CNPG receive insufficient therapies such as topical anti-inflammatory treatment and H1 antihistamines. However, some reports have shown that high-intensity excimer light (EL) therapy is effective for CNPG [4‐6]. EL therapy at a wavelength of 308 nm has a therapeutic effect with low cumulative UV dosage and a low risk of DNA damage because it requires a short irradiation time. It is safe and effective for the treatment of chronic skin diseases, including psoriasis, atopic dermatitis, and palmoplantar pustulosis [7‐9]. EL therapy is also an effective treatment for CNPG and related diseases because high-density light deeply penetrates the skin. We present two cases of severe CNPG treated successfully with EL therapy and oral prednisolone. …
Advertisement
- Title
- Excimer light therapy with systemic corticosteroids improved severe chronic nodular prurigo and altered peripheral nerve fibers in the epidermis
- Authors
-
Tsuyoshi Mitsuishi
Mitsutoshi Tominaga
Kazunori Miyata
Sumika Toyama
Utako Kimura
Yasushi Suga
Kenji Takamori
- Publication date
- 04-05-2022
- Publisher
- Springer London
- Keywords
-
Atopic Dermatitis
Prednisolone - Published in
-
Lasers in Medical Science / Issue 9/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X - DOI
- https://doi.org/10.1007/s10103-022-03570-8
This content is only visible if you are logged in and have the appropriate permissions.